SANUWAVE Health, Inc., headquartered in the United States, is a pioneering company in the medical technology industry, specialising in advanced wound care and regenerative medicine. Founded in 2001, SANUWAVE has made significant strides in developing innovative solutions that enhance healing processes, particularly through its proprietary Pulsed Acoustic Cellular Expression (PACE) technology. The company’s core offerings include the dermaPACE® system, designed for the treatment of diabetic foot ulcers and other chronic wounds, which sets it apart with its non-invasive approach and ability to stimulate cellular activity. With a strong market presence and a commitment to improving patient outcomes, SANUWAVE continues to lead the way in transforming wound care practices across major operational regions in the US and beyond.
How does SANUWAVE Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SANUWAVE Health, Inc.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SANUWAVE Health, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that SANUWAVE Health may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the company operates within the healthcare technology sector, it may face increasing pressure to adopt sustainable practices and transparency in emissions reporting in line with industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SANUWAVE Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

